NCT06893718 Treadmill Training With and Without Compression Stockings on Toe Walking and Balance in Children With Autism.
| NCT ID | NCT06893718 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2025-03-15 |
| Primary Completion | 2025-04-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2025-03-15 with a primary completion date of 2025-04-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Autism Spectrum Disorder (ASD) affects around 1.7% of US children, with co-occurring conditions like ADHD, anxiety, and epilepsy complicating daily functioning. Early intervention strategies, such as sensory-based therapies and physical exercises like treadmill training, are used to improve motor skills and overall functioning in children with ASD. A randomized controlled trial is being conducted to evaluate the impact of treadmill interventions on children with toe-walking behaviors. Participants will be assigned to either Group A or Group B, with treadmill sessions with or without compression stockings. The study aims to investigate the potential benefits of treadmill therapy as part of a multidisciplinary approach to treating ASD.
Eligibility Criteria
Inclusion Criteria: * Children with ASD who toe walk. * Gait disorder more than 30% of the time. * Compliance with our treatment protocol. * Children whose guardians agreed on the study Exclusion Criteria: * Associated orthopedic conditions. * Underlying genetic disorders. * Global developmental delay. * Patient's parents'/guardians' refusal to provide informed consent
Contact & Investigator
Qutbia Abaq Javed Cheema, MS-PPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06893718 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06893718 currently recruiting?
Yes, NCT06893718 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06893718 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06893718 clinical trial?
NCT06893718 is sponsored by Riphah International University. The principal investigator is Qutbia Abaq Javed Cheema, MS-PPT at Riphah International University. The trial plans to enroll 24 participants.